false
Catalog
The Lead Episode 10: A Discussion of Pulsed Field ...
The Lead Episode 10 Speaker Information
The Lead Episode 10 Speaker Information
Back to course
Pdf Summary
In this discussion article, the authors explore pulsed field ablation (PFA) as a potential treatment for atrial fibrillation (AF). They specifically focus on the PULSED AF Pivotal Trial, which investigates the safety and efficacy of PFA in patients with AF.<br /><br />The panel of experts consists of William H. Sauer, MD, FHRS, CCDS as the host, and contributors Paul C. Zei, MD, PhD, FHRS, and Nathaniel Steiger, MD. They disclose their affiliations and possible conflicts of interest, which include consulting, research, and stock ownership in various medical companies.<br /><br />PFA is a minimally invasive procedure that uses electric fields rather than heat to create lesions in the heart tissue. It has gained interest as a potential alternative to traditional catheter ablation methods for AF. The PULSED AF Pivotal Trial aims to evaluate the safety and effectiveness of PFA in achieving durable pulmonary vein isolation (PVI) and reducing AF burden in patients.<br /><br />During the discussion, the experts address the challenges posed by AF, including its prevalence, the limitations of current treatment options, and the need for alternative approaches. They highlight the potential advantages of PFA, such as its non-thermal nature, shorter procedure times, and the ability to create contiguous and transmural lesions. Additionally, they discuss the results of the PULSED AF Pivotal Trial, which have shown promising outcomes in terms of acute PVI procedures, procedural success rates, and reduction in AF burden.<br /><br />The panel acknowledges that further research and longer-term follow-up data are needed to fully evaluate the outcomes and safety of PFA compared to traditional catheter ablation methods. They also stress the importance of patient selection and appropriate training for physicians performing PFA procedures.<br /><br />In conclusion, this discussion article provides an overview of the PULSED AF Pivotal Trial and highlights the potential of PFA as a new approach for the treatment of AF. The experts emphasize the need for larger, randomized trials to validate the findings and expand on the knowledge of PFA in AF therapy.
Keywords
pulsed field ablation
atrial fibrillation
PULSED AF Pivotal Trial
treatment
safety
efficacy
minimally invasive procedure
electric fields
heart tissue
catheter ablation methods
Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy
|
Cookie Declaration
|
Linking Policy
|
Patient Education Disclaimer
|
State Nonprofit Disclosures
|
FAQ
×
Please select your language
1
English